
More than half of Germany's medium-sized companies expect an economic downturn next year, according to a survey by the BVMW business association.
Christoph Ahlhaus, the association's chief executive, said on Saturday that "superficial reforms are no longer enough to get Germany back on track."
He said businesses expect the federal government to finally deliver on long-promised structural reforms and concrete relief measures in areas such as bureaucracy, the labour market, taxation and energy costs.
According to the survey, 54% of companies expect an economic slowdown, while only 22% anticipate an upswing. In addition, 42% of respondents said they plan to scale back investment in 2026, the association said.
Medium-sized companies, known as the Mittelstand, form the backbone of Germany's economy and account for a large share of employment and investment.
The German economy contracted in 2023 and 2024, while growth is forecast to be minimal this year and no meaningful recovery is expected in 2026.
The BVMW surveyed more than 1,000 Mittelstand companies in an online poll conducted between December 18 and 23.
LATEST POSTS
- 1
Higher cost, worse coverage: Affordable Care Act enrollees say expiring subsidies will hit them hard - 2
Figure out How to Amplify Innovation and Infotainment Frameworks for Senior Drivers in SUVs - 3
Top Fascinating Organic products: Which One Might You Want to Attempt? - 4
Track down Your Optimal Conservative Vehicle: Famous Brands to Consider - 5
The Leonid meteor shower is peaking early this week. Here’s what to know
Trial of pro-Palestine activist begins
Israeli girl suffers cardiac arrest during sirens in Safed, hospitalized in serious condition
Vote in favor of Your #1 4K television: Lucidity and Drenching Matter
Eli Lilly weight-loss drug appears to suppress binge-eating signal, small study finds
Oil rises above $115 and Asia stocks slide as Iran war escalates
Becoming amazing at Arranging Pay Raises
Thousands of New York City nurses set to strike Monday if deal isn't reached with hospitals
AstraZeneca to acquire Modella AI to speed oncology drug research
Favored Vehicle for Seniors: Make Your Determination













